By InvitationNot Applicable

Addressing Psychosocial Comorbidities in HIV Treatment and Prevention 2b

United States75 participantsStarted 2022-08-15

Plain-language summary

The purpose of this study is to learn about ways to better support people living with HIV with their HIV treatment and cope with mental health challenges and/or substance use concerns.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age: 18 years or older
✓. HIV positive
✓. Evidence of uncontrolled virus (e.g., \> 20 copies/ml) within the past 12 months as verified by medical record
✓. Group 1: (Men who have sex with men (MSM) who have used stimulants within the past 4 months (approximately 10 participants))OR Group 2: transgender women (approximately 10 participants) OR Group 3: Emerging adults between the ages of 18 and 26 (inclusive; approximately 10 participants)

Exclusion criteria

✕. Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at the time of interview
✕. Active untreated, unstable, major mental illness (i.e., untreated psychosis or mania) that would interfere with study participation
✕. Opinion of the PI that the participant would be at risk for harm to self or others
✕. Currently receiving CBT for a psychiatric disorder, or received a course of CBT in the past year.

What they're measuring

Percentage of participants who completes the follow up assessment

Timeframe: 8 months

Trial details

NCT IDNCT05352061

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05

View on ClinicalTrials.gov More Medication Adherence trials